| Read Time: 4 minutes | news

Airbag Recalls, Public Safety, and Your Legal Rights

The news about the Takata airbag recall seems to get worse and worse. In addition to the ever-expanding recall, news sources report that manufacturer Takata became aware of the issue in 2004 and yet continued to manufacture a faulty design regardless of data culled from crash reports. Similarly, in the wake of the GM recall earlier in 2014, data...

Continue Reading

| Read Time: 3 minutes | news

Massive Airbag Recall: Are You In Danger?

In October 2014, a massive airbag recall of over 7.8 million vehicles was issued by the National Highway Traffic Safety Administration (NHTSA) over concerns that airbags from manufacturer Takata were faulty and dangerous. This recall covers numerous makes and models, affects vehicles worldwide, and continues to grow. Already this recall is substantially larger than the In October 2014, a...

Continue Reading

| Read Time: 4 minutes | news

Be Informed When Using Alternative Medicine

Do you use alternative medicine instead of mainstream methods of medicine, and how certain are you about its effectiveness on your overall health? Alternatives to traditional medicine – known broadly by such terms as alternative medicine, holistic medicine, naturopathy, homeopathy, and natural medicine – have in recent years become more popular across all segments of the population. However, alternative...

Continue Reading

| Read Time: < 1 minute | news

Zostavax Required To Add Shingles To Side Effects

August 2014 — A label change was required by the FDA to include shingles as a possible side effect after numerous reports of the vaccination causing shingles. Reference: Center for Biologics Evaluation and Research. “Zostavax.” U.S. Food and Drug Administration, FDA, www.fda.gov/vaccines-blood-biologics/vaccines/zostavax.

Continue Reading

| Read Time: < 1 minute | news

Byetta And Bydureon Settlements

2014 — AstraZeneca settled 84 Byetta and Bydureon cases related to cancer claims for an undisclosed amount. Reference:  Kirk, Austin. “Byetta Settlements Reached in 84 Cases, But Hundreds of Lawsuits Remain.” AboutLawsuitscom, 8 Aug. 2014, www.aboutlawsuits.com/byetta-settlements-cases-remain-68830/.

Continue Reading

| Read Time: < 1 minute | news

FDA Issued Safety Communication for Taxotere

June 2014 – The FDA issued a safety communication about the potential for patients to experience intoxication during or after the use of Taxotere due to the presence of ethanol in docetaxel. Reference: “FDA Warns That Cancer Drug Docetaxel May Cause Symptoms of Alcohol.” U.S. Food and Drug Administration, www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-cancer-drug-docetaxel-may-cause-symptoms-alcohol

Continue Reading

| Read Time: 3 minutes | news

The Dangers of Drunk Driving

Most of us have been affected by drunken driving in some way – whether through personal experience or through our acquaintance with someone else’s personal experience – and yet it continues to occur despite our awareness of the problem. In a society where it’s always “5 o’clock somewhere,” the legal ramifications of drinking and driving are well established, and...

Continue Reading

| Read Time: < 1 minute | Defective Consumer Devices

Relationship Between Exposure To Glyphosate And Cancer Supported By Scientific Studies

2014 — A relationship between exposure to glyphosate and B cell lymphoma was found in 2014 after researchers studied 44 different scientific publications.  The publications covered 32 years’ worth of data on non-Hodgkin’s lymphoma and pesticide exposure. Reference:  Moncivais, Katy. “Roundup Cancer Lawsuit: 2020 Updates & Settlements.” Consumer Safety, 8 Jan. 2021, https://www.consumersafety.org/product-lawsuits/roundup/

Continue Reading

| Read Time: < 1 minute | news

2013 Study Finds Higher Rate of Pancreatitis and Pancreatic Cancer

2013 — In 2013, the FDA was still investigating the link between incretin mimetics and pancreatic disease.  They released a drug safety communication reporting the possibility of incretin mimetics increasing the risk of pancreatitis as well as causing pre-cancerous changes in the pancreas.  They also cited a study, which was unpublished at the time, that found how the use...

Continue Reading

| Read Time: < 1 minute | news

Judicial Panel Transfers the First 53 Cases

August 2013 — In August 2013, the Judicial Panel on Multidistrict Litigation transferred the first 53 cases against Merck, Amylin, Eli Lilly and Novo Nordisk to MDL No. 2452. The original cases came from state courts in Arizona, California, Colorado, Kansas, Missouri, Oklahoma and Pennsylvania. Since all of the lawsuits claim the drugs caused pancreatic cancer and pancreatitis, the...

Continue Reading